Jean-Claude Mongrenier is a Doctor of Pharmacy. He is an alumnus of the IAE Caen and the London Business School, where he earned his MBA.

Before founding biolog-id in 2005, he occupied a series of posts in sales & marketing and general management for major American healthcare groups (Baxter, Dupont de Nemours, Johnson&Johnson, Chiron).

Between 2005 and 2016, he expanded the company according to his own vision: using RFID technology to manage and trace sensitive medical products. In 2016, himself becoming the Founder and Chairman of the Board.

Troy Hilsenroth served as the vice president and general manager of the medication adherence division at Omnicell, where he built and grew a global division over the last 10 years. Prior to Omnicell, Troy Hilsenroth held management and staff pharmacy positions at prominent healthcare systems.

In 2019, he became CEO of biolog-id LLC where he focused on driving the adoption of the company’s solutions and enhancing its R&D capabilities in the North American market. 

After 2 years in this position, Troy Hilsenroth has taken the lead of all biolog-id activities to support the biolog-id international deployment and to prepare the company for going public.

Amit Mayer now has over 20 years of experience in innovation impact across multiple companies, industries, and geographical areas.

Over his career, he held a variety of executive roles in innovation, marketing, instructional design, and analytics. His background includes global experience in several healthcare verticals including pharmaceuticals, chemotherapy, and personalized medicine.

In 2018, he joined biolog-id as General Manager, then as VP Innovation & Analytics before taking on the role of CIO in 2021.

‍

Bruno Chappert is a Senior Executive who is successful at devising strategies that create efficiencies, facilitate sustainable growth, and drive profitability across diverse environments.

During his international career, including the United States (Thales, IBM, Thomson, IN Groupe, etc.) he held various management responsibilities in the areas of Technology Development, Systems Integration, Supply Chains management, and Business Units General Management.

In the last ten years, Bruno played a key role in IN Groupe by setting up Digital Services in the area of Identification, Authentication, and Traceability and specifically led strategic key programs supporting the Health sector’s Digital Transformation.

Arnaud Saint-Michel began his career in financial auditing at KPMG, before garnering 20+ years’ experience in financial management roles for various French groups having major international operations in Europe, North America and Asia.

He supported these companies by providing them with the financial and human resources, the processes and the necessary tools to build sustainable growth and create value for their shareholders.

He joined Biolog-id in 2018 to support the hyper growth of the activity and structure the company for its IPO.